Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gianfranco Mancuso
Observed names:
G. Mancuso,
GIANFRANCO MANCUSO,
Mancuso, Gianfranco
Institution:
La Maddalena
Observed institutions:
Azienda Ospedaliero-Universitaria "Renato Dulbecco",
La Maddalena,
University of Palermo
OpenAlex ID:
A5033620626
First-Line Erlotinib Followed by Second-Line Cisplatin-Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer: The TORCH Randomized Trial
2012
·
Cesare Gridelli
, Fortunato Ciardiello
, et al.
·
Journal of Clinical Oncology
·
243
PDF
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: The CAPPA-2 study
2013
·
Alessandro Morabito
, Vittorio Gebbia
, et al.
·
Lung Cancer
·
55
Virtual Multidisciplinary Tumor Boards: A Narrative Review Focused on Lung Cancer
2021
·
Vittorio Gebbia
, Aurelia Guarini
, et al.
·
Pulmonary Therapy
·
51
PDF
Effect of Age Upon Airway Obstruction and Reversibility in Adult Patients With Asthma
1998
·
Vincenzo Bellia
, Fabio Cibella
, et al.
·
CHEST Journal
·
37
Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small-cell lung cancer: a pooled analysis of 6 randomized trials
2021
·
Piera Gargiulo
, Laura Arenare
, et al.
·
BMC Cancer
·
32
PDF
Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients
2008
·
Vittorio Gebbia
, Cesare Gridelli
, et al.
·
Lung Cancer
·
32
Quality of Life Analysis of TORCH, a Randomized Trial Testing First-Line Erlotinib Followed by Second-Line Cisplatin/Gemcitabine Chemotherapy in Advanced Non–Small-Cell Lung Cancer
2012
·
Massimo Di Maio
, Natasha B. Leighl
, et al.
·
Journal of Thoracic Oncology
·
30
PDF
High-dose Radiotherapy for Oligo-progressive NSCLC Receiving EGFR Tyrosine Kinase Inhibitors: Real World Data
2020
·
MARIACARMELA SANTARPIA
, GIUSEPPE ALTAVILLA
, et al.
·
In Vivo
·
20
PDF
First-line cisplatin with docetaxel or vinorelbine in patients with advanced non-small-cell lung cancer: A quality of life directed phase II randomized trial of Gruppo Oncologico Italia Meridionale
2009
·
Vittorio Gebbia
, Vito Lorusso
, et al.
·
Lung Cancer
·
19
Metronomic oral vinorelbine in patients with advanced non-small cell lung cancer progressing after nivolumab immunotherapy: a retrospective analysis
2020
·
Vittorio Gebbia
, Marco Maria Aiello
, et al.
·
ecancermedicalscience
·
7
PDF
EGFR tyrosine kinase inhibitor therapy continuation with high-dose hypofractionated radiotherapy in EGFR-mutated non-small cell lung cancer (NSCLC) patients with oligoprogressive disease.
2020
·
Mariacarmela Santarpia
, Maria Rosaria Valerio
, et al.
·
Journal of Clinical Oncology
·
2
Randomized phase III trial of gemcitabine and cisplatin versus gemcitabine alone in patients with advanced non-small cell lung cancer (NSCLC) and a performance status (PS) 2: CAPPA-2 study.
2013
·
Alessandro Morabito
, Vittorio Gebbia
, et al.
·
Journal of Clinical Oncology
·
2
Comprehensive Palliative Care in Patients with Lung Cancer Admitted to an Acute Palliative Care Unit
2026
·
Sebastiano Mercadante
, Gianfranco Mancuso
, et al.
·
Cancers
·
1
PDF
167P Chemotherapy-induced neutropenia and treatment efficacy in advanced non-small cell lung cancer (aNSCLC): A pooled analysis of 6 randomized trials
2021
·
P. Gargiulo
, R. Di Liello
, et al.
·
Journal of Thoracic Oncology
·
1
PDF
Listening understanding and acting (lung): focus on communicational issue in thoracic oncology
2018
·
Claudia Yvonne Finocchiaro
, Alessandra Rota
, et al.
·
Translational Cancer Research
·
1
A multicenter, randomised, phase III trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients. The STAD-1 trial.
2015
·
Alessandro Morabito
, Gennaro Daniele
, et al.
·
Journal of Clinical Oncology
·
1
Evolution of Therapy Decision-Making Process for Advanced Non-Small Cell Lung Cancer
2009
·
Vittorio Gebbia
, Gianfranco Mancuso
, et al.
·
Oncology
·
1
Pulmonary infections in an acute palliative care unit
2026
·
Sebastiano Mercadante
, Sofia Settepani
, et al.
·
Supportive Care in Cancer
A multicenter, randomised, phase 3 trial comparing fixed dose versus toxicity-adjusted dose of cisplatin + etoposide in advanced SCLC patients (pts). The STAD-1 trial
2015
·
G. Daniele
, A. Morabito
, et al.
·
Annals of Oncology
PDF
9140 Evaluation of treatment adherence, persistance, and quality of life in patients with advanced non-small cell lung cancer (ANSCLC) treated with erlotinib (e) as second-line therapy
2009
·
V. Gebbia
, P. Russo
, et al.
·
European Journal of Cancer Supplements
Author Index Vol. 77, Suppl. 1, 2009
2009
·
Antonio Rossi
, Domenico Galetta
, et al.
·
Oncology
PDF
Abstracts
2009
·
Antonio Rossi
, Domenico Galetta
, et al.
·
Oncology
Role of positron emission tomography (PET) in advanced stage non-small cell lung cancer patients treated with cisplatin-based doublets
2008
·
V. Gebbia
, U. Ficola
, et al.
·
European Journal of Cancer Supplements
PDF
Show more works
View as search
Works count:
28
Citation count:
535
H-index:
9
I10-index:
9
Year
Topic
Type